Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Payables: 2019-2024

Historic Payables for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $4.2 million.

  • Benitec Biopharma's Payables rose 137.98% to $6.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $16.7 million, marking a year-over-year increase of 14.33%. This contributed to the annual value of $4.2 million for FY2024, which is 28.91% up from last year.
  • As of FY2024, Benitec Biopharma's Payables stood at $4.2 million, which was up 28.91% from $3.2 million recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Payables ranged from a high of $4.2 million in FY2024 and a low of $741,000 during FY2020.
  • In the last 3 years, Benitec Biopharma's Payables had a median value of $3.2 million in 2023 and averaged $3.1 million.
  • In the last 5 years, Benitec Biopharma's Payables slumped by 70.29% in 2020 and then soared by 113.64% in 2022.
  • Over the past 5 years, Benitec Biopharma's Payables (Yearly) stood at $741,000 in 2020, then rose by 18.76% to $880,000 in 2021, then surged by 113.64% to $1.9 million in 2022, then spiked by 71.86% to $3.2 million in 2023, then grew by 28.91% to $4.2 million in 2024.